FSHD: Copy number variations on the theme of muscular dystrophy

Journal of Cell Biology

Volumn 191, Issue 6, 2010, Pages 1049-1060

  Cabianca, Daphne Selvaggia ^a,b   Gabellini, Davide ^b,c  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c DULBECCO TELETHON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE;

AUTOSOMAL DOMINANT DISORDER; CHROMATIN; CHROMOSOME 4Q; COPY NUMBER VARIATION; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; HUMAN; MUSCLE WEAKNESS; ORBICULARIS OCULI MUSCLE; ORBICULARIS ORIS MUSCLE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETICS; TANDEM REPEAT;

ANIMALS; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; GENE EXPRESSION; HUMANS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; TANDEM REPEAT SEQUENCES;

EID: 78650148935     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201007028     Document Type: Review

References (145)

1. Amrichová, J., E. Lukásová, S. Kozubek, and M. Kozubek. 2003. Nuclear and territorial topography of chromosome telomeres in human lymphocytes. Exp. Cell Res. 289:11-26. doi:10.1016/S0014-4827(03)00208-8
2. Ansseau, E., D. Laoudj-Chenivesse, A. Marcowycz, A. Tassin, C. Vanderplanck, S. Sauvage, M. Barro, I. Mahieu, A. Leroy, I. Leclercq, et al. 2009. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One. 4:e7482. doi:10.1371/journal.pone.0007482
3. Arashiro, P., I. Eisenberg, A.T. Kho, A.M. Cerqueira, M. Canovas, H.C. Silva, R.C. Pavanello, S. Verjovski-Almeida, L.M. Kunkel, and M. Zatz. 2009. Transcriptional regulation differs in affected facioscapulo-humeral muscular dystrophy patients compared to asymptomatic related carriers. Proc. Natl. Acad. Sci. USA. 106:6220-6225. doi:10.1073/pnas.0901573106
4. Bakker, E., C. Wijmenga, R.H. Vossen, G.W. Padberg, J. Hewitt, M. van der Wielen, K. Rasmussen, and R.R. Frants. 1995. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve. 2:S39-S44. doi:10.1002/mus.880181309
5. Bakker, E., M.J. Van der Wielen, E. Voorhoeve, P.F. Ippel, G.W. Padberg, R.R. Frants, and C. Wijmenga. 1996. Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases. J. Med. Genet. 33:29-35. doi:10.1136/jmg.33.1.29
6. Bernstein, B.E., A. Meissner, and E.S. Lander. 2007. The mammalian epigenome. Cell. 128:669-681. doi:10.1016/j.cell.2007.01.033
7. Bessonov, S., M. Anokhina, C.L. Will, H. Urlaub, and R. Lührmann. 2008. Isolation of an active step I spliceosome and composition of its RNP core. Nature. 452:846-850. doi:10.1038/nature06842
8. Blair, I.P., L.J. Adams, R.F. Badenhop, M.J. Moses, A. Scimone, J.A. Morris, L. Ma, C.P. Austin, J.A. Donald, P.B. Mitchell, and P.R. Schofield. 2002. A transcript map encompassing a susceptibility locus for bipolar affective disorder on chromosome 4q35. Mol. Psychiatry. 7:867-873. doi:10.1038/sj.mp. 4001113
9. Bodega, B., G.D. Ramirez, F. Grasser, S. Cheli, S. Brunelli, M. Mora, R. Meneveri, A. Marozzi, S. Mueller, E. Battaglioli, and E. Ginelli. 2009. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol. 7:41. doi:10.1186/1741-7007-7- 41
10. Bosnakovski, D., Z. Xu, E.J. Gang, C.L. Galindo, M. Liu, T. Simsek, H.R. Garner, S. Agha-Mohammadi, A. Tassin, F. Coppée, et al. 2008a. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 27:2766-2779. doi:10.1038/emboj.2008.201
11. Bosnakovski, D., S. Lamb, T. Simsek, Z. Xu, A. Belayew, R. Perlingeiro, and M. Kyba. 2008b. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp. Neurol. 214:87-96. doi:10.1016/j.expneurol.2008.07.022
12. Briese, M., B. Esmaeili, and D.B. Sattelle. 2005. Is spinal muscular atrophy the result of defects in motor neuron processes? Bioessays. 27:946-957. doi:10.1002/bies.20283
13. Buckingham, M. 2007. Skeletal muscle progenitor cells and the role of Pax genes. C. R. Biol. 330:530-533. doi:10.1016/j.crvi.2007.03.015
14. Cacurri, S., N. Piazzo, G. Deidda, E. Vigneti, G. Galluzzi, L. Colantoni, B. Merico, E. Ricci, and L. Felicetti. 1998. Sequence homology between 4qter and 10qter loci facilitates the instability of subtelomeric KpnI repeat units implicated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 63:181-190. doi:10.1086/301906
15. Calado, A., F.M. Tomé, B. Brais, G.A. Rouleau, U. Kühn, E. Wahle, and M. Carmo-Fonseca. 2000. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet. 9:2321-2328.
16. Campos, E.I., and D. Reinberg. 2009. Histones: annotating chromatin. Annu. Rev. Genet. 43:559-599. doi:10.1146/annurev.genet.032608.103928
17. Celegato, B., D. Capitanio, M. Pescatori, C. Romualdi, B. Pacchioni, S. Cagnin, A. Viganò, L. Colantoni, S. Begum, E. Ricci, et al. 2006. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics. 6:5303-5321. doi:10.1002/pmic.200600056
18. Chadwick, B.P. 2009. Macrosatellite epigenetics: the two faces of DXZ4 and D4Z4. Chromosoma. 118:675-681. doi:10.1007/s00412-009-0233-5
19. Chance, P.F., N. Abbas, M.W. Lensch, L. Pentao, B.B. Roa, P.I. Patel, and J.R. Lupski. 1994. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum. Mol. Genet. 3:223-228. doi:10.1093/hmg/3.2.223
20. Chen, T., and E. Li. 2004. Structure and function of eukaryotic DNA methyltransferases. Curr. Top. Dev. Biol. 60:55-89. doi:10.1016/S0070-2153(04) 60003-2
21. Cheung, P., C.D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell. 103:263-271. doi:10.1016/S0092- 8674(00)00118-5
22. Conrad, D.F., D. Pinto, R. Redon, L. Feuk, O. Gokcumen, Y. Zhang, J. Aerts, T.D. Andrews, C. Barnes, P. Campbell, et al; Wellcome Trust Case Control Consortium. 2010. Origins and functional impact of copy number variation in the human genome. Nature. 464:704-712. doi:10.1038/nature08516
23. Davidovic, L., S. Sacconi, E.G. Bechara, S. Delplace, M. Allegra, C. Desnuelle, and B. Bardoni. 2008. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients. J. Med. Genet. 45:679-685. doi: 10.1136/jmg.2008.060541
24. de Greef, J.C., R.J. Lemmers, B.G. van Engelen, S. Sacconi, S.L. Venance, R.R. Frants, R. Tawil, and S.M. van der Maarel. 2009. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum. Mutat. 30:1449-1459. doi:10.1002/humu.21091
25. Deidda, G., S. Cacurri, N. Piazzo, and L. Felicetti. 1996. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J. Med. Genet. 33:361-365. doi:10.1136/jmg.33.5.361 (Pubitemid 26147865)
26. Dekker, J., K. Rippe, M. Dekker, and N. Kleckner. 2002. Capturing chromosome conformation. Science. 295:1306-1311. doi:10.1126/science.1067799
27. Dixit, M., E. Ansseau, A. Tassin, S. Winokur, R. Shi, H. Qian, S. Sauvage, C. Mattéotti, A.M. van Acker, O. Leo, et al. 2007. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. USA. 104:18157-18162. doi:10.1073/pnas.0708659104
28. Edwards, R.A., and J. Bryan. 1995. Fascins, a family of actin bundling proteins. Cell Motil. Cytoskeleton. 32:1-9. doi:10.1002/cm.970320102
29. Faustmann, P.M., J. Farahati, B. Rupilius, R. Dux, M.C. Koch, and C. Reiners. 1996. Cardiac involvement in facio-scapulo-humeral muscular dystrophy: a family study using Thallium-201 single-photonemission- computed tomography. J. Neurol. Sci. 144:59-63. doi:10.1016/S0022-510X(96)00145-1
30. Ferrai, C., I.J. de Castro, L. Lavitas, M. Chotalia, and A. Pombo. 2010. Gene positioning. Cold Spring Harb Perspect Biol. 2:a000588. doi:10.1101/cshperspect.a000588
31. Filippova, G.N. 2008. Genetics and epigenetics of the multifunctional protein CTCF. Curr. Top. Dev. Biol. 80:337-360. doi:10.1016/S0070-2153(07)80009- 3
32. Fitzsimons, R.B., E.B. Gurwin, and A.C. Bird. 1987. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain. 110:631-648. doi:10.1093/brain/110.3.631
33. Flanigan, K.M., C.M. Coffeen, L. Sexton, D. Stauffer, S. Brunner, and M.F. Leppert. 2001. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul. Disord. 11:525-529. doi:10.1016/S0960-8966(01)00201-2
34. Funakoshi, M., K. Goto, and K. Arahata. 1998. Epilepsy and mental retardation in a subset of early onset 4q35-facioscapulohumeral muscular dystrophy. Neurology. 50:1791-1794.
35. Gabellini, D., M.R. Green, and R. Tupler. 2002. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell. 110:339-348. doi:10.1016/S0092-8674(02)00826-7
36. Gabellini, D., M.R. Green, and R. Tupler. 2004. When enough is enough: genetic diseases associated with transcriptional derepression. Curr. Opin. Genet. Dev. 14:301-307. doi:10.1016/j.gde.2004.04.010
37. Gabellini, D., G. D'Antona, M. Moggio, A. Prelle, C. Zecca, R. Adami, B. Angeletti, P. Ciscato, M.A. Pellegrino, R. Bottinelli, et al. 2006. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature. 439:973-977.
38. Gabriëls, J., M.C. Beckers, H. Ding, A. De Vriese, S. Plaisance, S.M. van der Maarel, G.W. Padberg, R.R. Frants, J.E. Hewitt, D. Collen, and A. Belayew. 1999. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene. 236:25-32. doi:10.1016/S0378-1119(99)00267-X
39. Giacalone, J., J. Friedes, and U. Francke. 1992. A novel GC-rich human macrosatellite VNTR in Xq24 is differentially methylated on active and inactive X chromosomes. Nat. Genet. 1:137-143. doi:10.1038/ng0592-137
40. Gilbert, J.R., J.M. Stajich, M.C. Speer, J.M. Vance, C.S. Stewart, L.H. Yamaoka, F. Samson, M. Fardeau, T.G. Potter, A.D. Roses, et al. 1992. Linkage studies in facioscapulohumeral muscular dystrophy (FSHD). Am. J. Hum. Genet. 51:424-427.
41. Gonzalez, E., H. Kulkarni, H. Bolivar, A. Mangano, R. Sanchez, G. Catano, R.J. Nibbs, B.I. Freedman, M.P. Quinones, M.J. Bamshad, et al. 2005. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 307:1434-1440. doi:10.1126/science.1101160
42. Goto, K., J.H. Lee, C. Matsuda, K. Hirabayashi, T. Kojo, A. Nakamura, Y. Mitsunaga, T. Furukawa, K. Sahashi, and K. Arahata. 1995. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations. Neuromuscul. Disord. 5:201-208. doi:10.1016/0960-8966(94)00055-E
43. Grewal, P.K., L.C. Todd, S. van der Maarel, R.R. Frants, and J.E. Hewitt. 1998. FRG1, a gene in the FSH muscular dystrophy region on human chromosome 4q35, is highly conserved in vertebrates and invertebrates. Gene. 216:13-19. doi:10.1016/S0378-1119(98)00334-5
44. Griggs, R.C., R. Tawil, D. Storvick, J.R. Mendell, and M.R. Altherr. 1993. Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases. Neurology. 43:2369-2372.
45. Griggs, R.C., R. Tawil, M. McDermott, J. Forrester, D. Figlewicz, and B. Weiffenbach; FSH-DY Group. 1995. Monozygotic twins with facioscapulo-humeral dystrophy (FSHD): implications for genotype/phenotype correlation. Muscle Nerve. 2:S50-S55. doi:10.1002/mus.880181311
46. Gu, W., F. Zhang, and J.R. Lupski. 2008. Mechanisms for human genomic rearrangements. Pathogenetics. 1:4. doi:10.1186/1755-8417-1-4
47. Guelen, L., L. Pagie, E. Brasset, W. Meuleman, M.B. Faza, W. Talhout, B.H. Eussen, A. de Klein, L. Wessels, W. de Laat, and B. van Steensel. 2008. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature. 453:948-951. doi:10.1038/nature06947 (Pubitemid 351832561)
48. Hanel, M.L., R.D. Wuebbles, and P.L. Jones. 2009. Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev. Dyn. 238:1502-1512. doi:10.1002/dvdy.21830
49. Hanel, M.L., C.Y. Sun, T.I. Jones, S.W. Long, S. Zanotti, D. Milner, and P.L. Jones. 2010. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein. Differentiation.
50. Hark, A.T., C.J. Schoenherr, D.J. Katz, R.S. Ingram, J.M. Levorse, and S.M. Tilghman. 2000. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature. 405:486-489. doi:10.1038/35013106
51. Hetzer, M.W. 2010. The nuclear envelope. Cold Spring Harb Perspect Biol. 2:a000539. doi:10.1101/cshperspect.a000539
52. Hewitt, J.E., R. Lyle, L.N. Clark, E.M. Valleley, T.J. Wright, C. Wijmenga, J.C. van Deutekom, F. Francis, P.T. Sharpe, M. Hofker, et al. 1994. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 3:1287-1295. doi:10.1093/hmg/3.8.1287
53. Ho, L., and G.R. Crabtree. 2010. Chromatin remodelling during development. Nature. 463:474-484. doi:10.1038/nature08911
54. Hsu, Y.D., M.C. Kao, W.C. Shyu, J.C. Lin, N.E. Huang, H.F. Sun, K.D. Yang, and W.L. Tsao. 1997. Application of chromosome 4q35-qter marker (pFR-1) for DNA rearrangement of facioscapulohumeral muscular dystrophy patients in Taiwan. J. Neurol. Sci. 149:73-79. doi:10.1016/S0022-510X(97)05394-X
55. Jiang, G., F. Yang, P.G. van Overveld, V. Vedanarayanan, S. van der Maarel, and M. Ehrlich. 2003. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum. Mol. Genet. 12:2909-2921. doi:10.1093/hmg/ddg323
56. Kilmer, D.D., R.T. Abresch, M.A. McCrory, G.T. Carter, W.M. Fowler Jr., E.R. Johnson, and C.M. McDonald. 1995. Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am. J. Phys. Med. Rehabil. 74:S131-S139. doi:10.1097/00002060-199509001-00007
57. Kim, S.K., J. Lund, M. Kiraly, K. Duke, M. Jiang, J.M. Stuart, A. Eizinger, B.N. Wylie, and G.S. Davidson. 2001. A gene expression map for Caenorhabditis elegans. Science. 293:2087-2092. doi:10.1126/science.1061603 (Pubitemid 32848057)
58. Kim, J., A. Kollhoff, A. Bergmann, and L. Stubbs. 2003. Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum. Mol. Genet. 12:233-245. doi:10.1093/hmg/ddg028
59. Klinge, L., M. Eagle, I.D. Haggerty, C.E. Roberts, V. Straub, and K.M. Bushby. 2006. Severe phenotype in infantile facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 16:553-558. doi:10.1016/j.nmd.2006.06.008
60. Klooster, R., K. Straasheijm, B. Shah, J. Sowden, R. Frants, C. Thornton, R. Tawil, and S. van der Maarel. 2009. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur. J. Hum. Genet. 17:1615-1624. doi:10.1038/ejhg.2009.62
61. Ko, C.Y., H.C. Hsu, M.R. Shen, W.C. Chang, and J.M. Wang. 2008. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/ polycomb group/DNA methyltransferase complex. J. Biol. Chem. 283: 30919-30932. doi:10.1074/jbc.M804029200
62. Kogi, M., S. Fukushige, C. Lefevre, S. Hadano, and J.E. Ikeda. 1997. A novel tandem repeat sequence located on human chromosome 4p: isolation and characterization. Genomics. 42:278-283. doi:10.1006/geno.1997.4746
63. Kondo, T., M.P. Bobek, R. Kuick, B. Lamb, X. Zhu, A. Narayan, D. Bourc'his, E. Viegas-Péquignot, M. Ehrlich, and S.M. Hanash. 2000. Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum. Mol. Genet. 9:597-604. doi:10.1093/hmg/9.4.597
64. Kowaljow, V., A. Marcowycz, E. Ansseau, C.B. Conde, S. Sauvage, C. Mattéotti, C. Arias, E.D. Corona, N.G. Nuñez, O. Leo, et al. 2007. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 17:611-623. doi:10.1016/j.nmd.2007.04.002
65. Landoyzy, L., and J. Dejerine. 1886. Contribution à ĺtude de la myopathie atrophique progressive (myopathie atrophique progressive, à type scapulohuméral. Comptes Rendus De La Société De Biologie. 38:478-481.
66. Laoudj-Chenivesse, D., G. Carnac, C. Bisbal, G. Hugon, S. Bouillot, C. Desnuelle, Y. Vassetzky, and A. Fernandez. 2005. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med. 83:216-224. doi:10.1007/s00109-004-0583-7
67. Lemmers, R.J., S.M. van der Maarel, J.C. van Deutekom, M.J. van der Wielen, G. Deidda, H.G. Dauwerse, J. Hewitt, M. Hofker, E. Bakker, G.W. Padberg, and R.R. Frants. 1998. Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum. Mol. Genet. 7:1207-1214. doi:10.1093/hmg/7.8.1207
68. Lemmers, R.J., P. de Kievit, L. Sandkuijl, G.W. Padberg, G.J. van Ommen, R.R. Frants, and S.M. van der Maarel. 2002. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat. Genet. 32:235-236. doi:10.1038/ng999
69. Lemmers, R.J., M. Osborn, T. Haaf, M. Rogers, R.R. Frants, G.W. Padberg, D.N. Cooper, S.M. van der Maarel, and M. Upadhyaya. 2003. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology. 61:178-183. (Pubitemid 36875297)
70. Lemmers, R.J., M. Wohlgemuth, K.J. van der Gaag, P.J. van der Vliet, C.M. van Teijlingen, P. de Knijff, G.W. Padberg, R.R. Frants, and S.M. van der Maarel. 2007. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81:884-894. doi:10.1086/521986
71. Lemmers, R.J., P.J. van der Vliet, K.J. van der Gaag, S. Zuniga, R.R. Frants, P. de Knijff, and S.M. van der Maarel. 2010a. Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am. J. Hum. Genet. 86:364-377. doi:10.1016/j.ajhg.2010.01.035
72. Lemmers, R.J., P.J. van der Vliet, R. Klooster, S. Sacconi, P. Camaño, J.G. Dauwerse, L. Snider, K.R. Straasheijm, G.J. van Ommen, G.W. Padberg, et al. 2010b. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science. 329:1650-1653. doi:10.1126/science.1189044
73. Li, K., C.K. Warner, J.A. Hodge, S. Minoshima, J. Kudoh, R. Fukuyama, M. Maekawa, Y. Shimizu, N. Shimizu, and D.C. Wallace. 1989. A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed. J. Biol. Chem. 264:13998-14004.
74. Liu, Q., T.I. Jones, V.W. Tang, W.M. Brieher, and P.L. Jones. 2010. Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J. Cell Sci. 123:1116-1123. doi:10.1242/jcs.058958
75. Ludérus, M.E., B. van Steensel, L. Chong, O.C. Sibon, F.F. Cremers, and T. de Lange. 1996. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex. J. Cell Biol. 135:867-881. doi:10.1083/jcb.135.4.867
76. Lunt, P.W., P.E. Jardine, M.C. Koch, J. Maynard, M. Osborn, M. Williams, P.S. Harper, and M. Upadhyaya. 1995. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35- facioscapulohumeral muscular dystrophy (FSHD). Hum. Mol. Genet. 4:951-958. doi:10.1093/hmg/4.5.951
77. Lyle, R., T.J. Wright, L.N. Clark, and J.E. Hewitt. 1995. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics. 28:389-397. doi:10.1006/geno.1995.1166
78. Maeda, R.K., and F. Karch. 2007. Making connections: boundaries and insulators in Drosophila. Curr. Opin. Genet. Dev. 17:394-399. doi:10.1016/j.gde.2007.08.002
79. Masny, P.S., U. Bengtsson, S.A. Chung, J.H. Martin, B. van Engelen, S.M. van der Maarel, and S.T. Winokur. 2004. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? Hum. Mol. Genet. 13:1857-1871. doi:10.1093/hmg/ddh205
80. Miura, K., T. Kumagai, A. Matsumoto, E. Iriyama, K. Watanabe, K. Goto, and K. Arahata. 1998. Two cases of chromosome 4q35-linked early onset facioscapulohumeral muscular dystrophy with mental retardation and epilepsy. Neuropediatrics. 29:239-241. doi:10.1055/s-2007-973568
81. Nagele, R.G., A.Q. Velasco, W.J. Anderson, D.J. McMahon, Z. Thomson, J. Fazekas, K. Wind, and H. Lee. 2001. Telomere associations in interphase nuclei: possible role in maintenance of interphase chromosome topology. J. Cell Sci. 114:377-388.
82. Neguembor, M.V., and D. Gabellini. 2010. In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy. Epigenomics. 2:271-287. doi:10.2217/epi.10.8
83. Nightingale, K.P., L.P. O'Neill, and B.M. Turner. 2006. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet. Dev. 16:125-136. doi:10.1016/j.gde.2006.02. 015
84. Osborne, R.J., S. Welle, S.L. Venance, C.A. Thornton, and R. Tawil. 2007. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology. 68:569-577. doi:10.1212/01.wnl.0000251269.31442. d9 (Pubitemid 46303603)
85. Ottaviani, A., S. Rival-Gervier, A. Boussouar, A.M. Foerster, D. Rondier, S. Sacconi, C. Desnuelle, E. Gilson, and F. Magdinier. 2009a. The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet. 5:e1000394. doi:10.1371/journal. pgen.1000394
86. Ottaviani, A., C. Schluth-Bolard, S. Rival-Gervier, A. Boussouar, D. Rondier, A.M. Foerster, J. Morere, S. Bauwens, S. Gazzo, E. Callet-Bauchu, et al. 2009b. Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF. EMBO J. 28:2428-2436. doi:10.1038/emboj.2009.201
87. Padberg, G.W. 1982. Facioscapulohumeral disease. Thesis. Leiden University, Leiden, Netherlands.
88. Padberg, G.W., P.W. Lunt, M. Koch, and M. Fardeau. 1991. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 1:231-234. doi:10.1016/0960-8966(91)90094-9
89. Padberg, G.W., O.F. Brouwer, R.J. de Keizer, G. Dijkman, C. Wijmenga, J.J. Grote, and R.R. Frants. 1995. On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2:S73-S80. doi:10.1002/mus.880181314
90. Pandya, S., W.M. King, and R. Tawil. 2008. Facioscapulohumeral dystrophy. Phys. Ther. 88:105-113. doi:10.2522/ptj.20070104
91. Petrov, A., I. Pirozhkova, G. Carnac, D. Laoudj, M. Lipinski, and Y.S. Vassetzky. 2006. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc. Natl. Acad. Sci. USA. 103:6982-6987. doi:10.1073/pnas.0511235103
92. Petrov, A., J. Allinne, I. Pirozhkova, D. Laoudj, M. Lipinski, and Y.S. Vassetzky. 2008. A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: implications for the facio-scapulo-humeral dystrophy. Genome Res. 18:39-45. doi:10.1101/gr.6620908
93. Pirozhkova, I., A. Petrov, P. Dmitriev, D. Laoudj, M. Lipinski, and Y. Vassetzky. 2008. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One. 3:e3389. doi:10.1371/journal.pone.0003389
94. Rappsilber, J., U. Ryder, A.I. Lamond, and M. Mann. 2002. Large-scale proteomic analysis of the human spliceosome. Genome Res. 12:1231-1245. doi:10.1101/gr.473902
95. Ricci, E., G. Galluzzi, G. Deidda, S. Cacurri, L. Colantoni, B. Merico, N. Piazzo, S. Servidei, E. Vigneti, V. Pasceri, et al. 1999. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann. Neurol. 45:751-757. doi:10.1002/1531-8249(199906)45:6〈751:: AID-ANA9〉3.0.CO;2-M
96. Rijkers, T., G. Deidda, S. van Koningsbruggen, M. van Geel, R.J. Lemmers, J.C. van Deutekom, D. Figlewicz, J.E. Hewitt, G.W. Padberg, R.R. Frants, and S.M. van der Maarel. 2004. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J. Med. Genet. 41:826-836. doi:10.1136/jmg.2004.019364
97. Rossi, M., E. Ricci, L. Colantoni, G. Galluzzi, R. Frusciante, P.A. Tonali, and L. Felicetti. 2007. The Facioscapulohumeral muscular dystrophy region on 4qter and the homologous locus on 10qter evolved independently under different evolutionary pressure. BMC Med. Genet. 8:8. doi: 10.1186/1471-2350-8-8
98. Ruthenburg, A.J., H. Li, D.J. Patel, and C.D. Allis. 2007. Multivalent engagement of chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol. 8:983-994. doi:10.1038/nrm2298
99. Saito, Y., S. Miyashita, A. Yokoyama, H. Komaki, A. Seki, Y. Maegaki, and K. Ohno. 2007. Facioscapulohumeral muscular dystrophy with severe mental retardation and epilepsy. Brain Dev. 29:231-233. doi:10.1016/j.braindev.2006.08. 012 (Pubitemid 46283289)
100. Simon, J.A., and R.E. Kingston. 2009. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. Rev. Mol. Cell Biol. 10:697-708.
101. Snider, L., A. Asawachaicharn, A.E. Tyler, L.N. Geng, L.M. Petek, L. Maves, D.G. Miller, R.J. Lemmers, S.T. Winokur, R. Tawil, et al. 2009. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 18:2414-2430. doi:10.1093/hmg/ddp180
102. Snider, L., L.N. Geng, R.J. Lemmers, M. Kyba, C.B. Ware, A.M. Nelson, R. Tawil, G.N. Filippova, S.M. van der Maarel, S.J. Tapscott, and D.G. Miller. 2010. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6:e1001181. doi:10.1371/journal.pgen.1001181
103. Spector, D.L. 2001. Nuclear domains. J. Cell Sci. 114:2891-2893.
104. Stankiewicz, P., and J.R. Lupski. 2010. Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61:437-455. doi:10.1146/annurev-med-100708-204735
105. Stranger, B.E., M.S. Forrest, M. Dunning, C.E. Ingle, C. Beazley, N. Thorne, R. Redon, C.P. Bird, A. de Grassi, C. Lee, et al. 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 315:848-853. doi:10.1126/science.1136678
106. Suzuki, M.M., and A. Bird. 2008. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9:465-476. doi:10.1038/nrg2341
107. Tam, R., K.P. Smith, and J.B. Lawrence. 2004. The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. J. Cell Biol. 167:269-279. doi:10.1083/jcb.200403128 (Pubitemid 39435070)
108. Tawil, R., and S.M. Van Der Maarel. 2006. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 34:1-15. doi:10.1002/mus.20522
109. Tawil, R., D. Storvick, T.E. Feasby, B. Weiffenbach, and R.C. Griggs. 1993. Extreme variability of expression in monozygotic twins with FSH muscular dystrophy. Neurology. 43:345-348.
110. Tawil, R., J. Forrester, R.C. Griggs, J. Mendell, J. Kissel, M. McDermott, W. King, B. Weiffenbach, and D. Figlewicz; The FSH-DY Group. 1996. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. Ann. Neurol. 39:744-748. doi:10.1002/ana.410390610
111. Tawil, R., D.A. Figlewicz, R.C. Griggs, and B. Weiffenbach; FSH Consortium. 1998. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann. Neurol. 43:279-282. doi:10.1002/ana.410430303
112. Tonini, M.M., M.R. Passos-Bueno, A. Cerqueira, S.R. Matioli, R. Pavanello, and M. Zatz. 2004. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul. Disord. 14:33-38. doi:10.1016/j.nmd.2003.07.001
113. Trevisan, C.P., E. Pastorello, M. Armani, C. Angelini, G. Nante, G. Tomelleri, P. Tonin, T. Mongini, L. Palmucci, G. Galluzzi, et al. 2006. Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia. Eur. Neurol. 56:1-5. doi:10.1159/000094248
114. Trevisan, C.P., E. Pastorello, M. Ermani, C. Angelini, G. Tomelleri, P. Tonin, T. Mongini, L. Palmucci, G. Galluzzi, R.G. Tupler, et al. 2008. Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Audiol. Neurootol. 13:1-6. doi:10.1159/000107431
115. Tsumagari, K., L. Qi, K. Jackson, C. Shao, M. Lacey, J. Sowden, R. Tawil, V. Vedanarayanan, and M. Ehrlich. 2008. Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers. Nucleic Acids Res. 36:2196-2207. doi:10.1093/nar/gkn055
116. Tupler, R., and D. Gabellini. 2004. Molecular basis of facioscapulohumeral muscular dystrophy. Cell. Mol. Life Sci. 61:557-566. doi:10.1007/s00018-003-3285-3
117. Tupler, R., A. Berardinelli, L. Barbierato, R. Frants, J.E. Hewitt, G. Lanzi, P. Maraschio, and L. Tiepolo. 1996. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet. 33:366-370. doi:10.1136/jmg.33.5.366
118. Tupler, R., L. Barbierato, M. Memmi, C.A. Sewry, D. De Grandis, P. Maraschio, L. Tiepolo, and A. Ferlini. 1998. Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J. Med. Genet. 35:778-783. doi:10.1136/jmg.35.9.778
119. Upadhyaya, M., J. Maynard, M. Osborn, P. Jardine, P.S. Harper, and P. Lunt. 1995. Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle Nerve. 2:S45-S49. doi:10.1002/mus.880181310
120. van der Maarel, S.M., G. Deidda, R.J. Lemmers, P.G. van Overveld, M. van der Wielen, J.E. Hewitt, L. Sandkuijl, B. Bakker, G.J. van Ommen, G.W. Padberg, and R.R. Frants. 2000. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am. J. Hum. Genet. 66:26-35. doi:10.1086/302730
121. van der Maarel, S.M., R.R. Frants, and G.W. Padberg. 2007. Facioscapulohumeral muscular dystrophy. Biochim. Biophys. Acta. 1772:186-194.
122. van Deutekom, J.C., C. Wijmenga, E.A. van Tienhoven, A.M. Gruter, J.E. Hewitt, G.W. Padberg, G.J. van Ommen, M.H. Hofker, and R.R. Frants. 1993. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2:2037-2042. doi:10.1093/hmg/2.12. 2037
123. van Deutekom, J.C., E. Bakker, R.J. Lemmers, M.J. van der Wielen, E. Bik, M.H. Hofker, G.W. Padberg, and R.R. Frants. 1996a. Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum. Mol. Genet. 5:1997-2003. doi:10.1093/hmg/5.12.1997
124. van Deutekom, J.C., R.J. Lemmers, P.K. Grewal, M. van Geel, S. Romberg, H.G. Dauwerse, T.J. Wright, G.W. Padberg, M.H. Hofker, J.E. Hewitt, and R.R. Frants. 1996b. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum. Mol. Genet. 5:581-590. doi:10.1093/hmg/5.5.581
125. van Geel, M., L.J. Heather, R. Lyle, J.E. Hewitt, R.R. Frants, and P.J. de Jong. 1999. The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements. Genomics. 61:55-65. doi:10.1006/geno.1999.5942
126. van Geel, M., M.C. Dickson, A.F. Beck, D.J. Bolland, R.R. Frants, S.M. van der Maarel, P.J. de Jong, and J.E. Hewitt. 2002. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics. 79:210-217. doi:10.1006/geno.2002.6690
127. van Koningsbruggen, S., R.W. Dirks, A.M. Mommaas, J.J. Onderwater, G. Deidda, G.W. Padberg, R.R. Frants, and S.M. van der Maarel. 2004. FRG1P is localised in the nucleolus, Cajal bodies, and speckles. J. Med. Genet. 41:e46. doi:10.1136/jmg 2003.012781
128. van Koningsbruggen, S., K.R. Straasheijm, E. Sterrenburg, N. de Graaf, H.G. Dauwerse, R.R. Frants, and S.M. van der Maarel. 2007. FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma. 116:53-64. doi:10.1007/s00412-006-0083-3 (Pubitemid 46179022)
129. van Overveld, P.G., R.J. Lemmers, G. Deidda, L. Sandkuijl, G.W. Padberg, R.R. Frants, and S.M. van der Maarel. 2000. Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity. Hum. Mol. Genet. 9:2879-2884. doi:10.1093/hmg/9.19.2879
130. van Overveld, P.G., R.J. Lemmers, L.A. Sandkuijl, L. Enthoven, S.T. Winokur, F. Bakels, G.W. Padberg, G.J. van Ommen, R.R. Frants, and S.M. van der Maarel. 2003. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35:315-317. doi: 10.1038/ng1262
131. Warburton, P.E., D. Hasson, F. Guillem, C. Lescale, X. Jin, and G. Abrusan. 2008. Analysis of the largest tandemly repeated DNA families in the human genome. BMC Genomics. 9:533. doi:10.1186/1471-2164-9-533
132. Weierich, C., A. Brero, S. Stein, J. von Hase, C. Cremer, T. Cremer, and
133. Weiffenbach, B., J. Dubois, D. Storvick, R. Tawil, S.J. Jacobsen, J. Gilbert, C. Wijmenga, J.R. Mendell, S. Winokur, M.R. Altherr, et al. 1993. Mapping the facioscapulohumeral muscular dystrophy gene is complicated by chromsome 4q35 recombination events. Nat. Genet. 4:165-169. doi:10.1038/ng0693- 165
134. Wijmenga, C., R.R. Frants, O.F. Brouwer, P. Moerer, J.L. Weber, and G.W. Padberg. 1990. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 336:651-653. doi:10.1016/0140-6736(90)92148-B (Pubitemid 20288865)
135. Wijmenga, C., G.W. Padberg, P. Moerer, J. Wiegant, L. Liem, O.F. Brouwer, E.C. Milner, J.L. Weber, G.B. van Ommen, L.A. Sandkuyl, et al. 1991. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics. 9:570-575. doi:10.1016/0888-7543(91)90348-I
136. Wijmenga, C., J.E. Hewitt, L.A. Sandkuijl, L.N. Clark, T.J. Wright, H.G. Dauwerse, A.M. Gruter, M.H. Hofker, P. Moerer, R. Williamson, et al. 1992. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat. Genet. 2:26-30. doi: 10.1038/ng0992-26
137. Winokur, S.T., U. Bengtsson, J. Feddersen, K.D. Mathews, B. Weiffenbach, H. Bailey, R.P. Markovich, J.C. Murray, J.J. Wasmuth, M.R. Altherr, et al. 1994. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res. 2:225-234. doi:10.1007/BF01553323
138. Winokur, S.T., Y.W. Chen, P.S. Masny, J.H. Martin, J.T. Ehmsen, S.J. Tapscott, S.M. van der Maarel, Y. Hayashi, and K.M. Flanigan. 2003a. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12:2895-2907. doi:10.1093/hmg/ddg327
139. Winokur, S.T., K. Barrett, J.H. Martin, J.R. Forrester, M. Simon, R. Tawil, S.A. Chung, P.S. Masny, and D.A. Figlewicz. 2003b. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord. 13:322-333. doi:10.1016/S0960-8966(02) 00284-5
140. Wu, S., Y.C. Hu, H. Liu, and Y. Shi. 2009. Loss of YY1 impacts the heterochromatic state and meiotic double-strand breaks during mouse spermatogenesis. Mol. Cell. Biol. 29:6245-6256. doi:10.1128/MCB.00679-09
141. Wuebbles, R.D., M.L. Hanel, and P.L. Jones. 2009. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis Model Mech. 2:267-274. doi:10.1242/dmm.002261
142. Wuebbles, R.D., S.W. Long, M.L. Hanel, and P.L. Jones. 2010. Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol. 3:386-400.
143. Zatz, M., S.K. Marie, M.R. Passos-Bueno, M. Vainzof, S. Campiotto, A. Cerqueira, C. Wijmenga, G. Padberg, and R. Frants. 1995. High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am. J. Hum. Genet. 56:99-105.
144. Zatz, M., S.K. Marie, A. Cerqueira, M. Vainzof, R.C. Pavanello, and M.R. Passos-Bueno. 1998. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am. J. Med. Genet. 77:155-161. doi:10.1002/(SICI)1096-8628(19980501)77:2〈155::AID- AJMG9〉3.0.CO;2-R
145. Zeng, W., J.C. de Greef, Y.Y. Chen, R. Chien, X. Kong, H.C. Gregson, S.T. Winokur, A. Pyle, K.D. Robertson, J.A. Schmiesing, et al. 2009. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 5:e1000559. doi:10.1371/journal.pgen.1000559